Blockchain Registration Transaction Record

DuLac Farmaceutici Pursues U.S. Retail Partners After ECRM 2026

DuLac Farmaceutici seeks U.S. retail partners after ECRM 2026, expanding its Italian dermo-cosmetic portfolio beyond Amazon and OneLavi.

This news matters because it signals the continued expansion of European pharmaceutical brands into the U.S. market, offering consumers more options for high-quality, botanically-based dermo-cosmetic products. DuLac’s move could lead to increased availability of its popular Arnica Gel and other Italian-formulated products in mainstream retail channels, giving shoppers easier access to trusted European pharmacy heritage. For retailers, partnering with DuLac means tapping into a growing demand for natural, effective skincare and wellness solutions, backed by strong consumer ratings. Ultimately, this expansion could raise the bar for product quality and innovation in the U.S. health and beauty sector.